Showing results (5471-5480 of 5,703) with videos related to
Sort By:
Pageof 571
The Oncologist|March 17, 2023
Cancer Demographics and Time-to-Care in BelizeWayne Wong, James C Dickerson, Yannis K Valtis, et al.The Oncologist|March 21, 2023
Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group StudyAri Pelcovits, Peter Barth, John L Reagan, et al.The Oncologist|March 21, 2023
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast CancerXuan Ge, Carolyn E Behrendt, Susan E Yost, et al.The Oncologist|August 7, 2016
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical TrialHao Peng, Lei Chen, Yuan Zhang, et al.The Oncologist|July 10, 2015
Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential BiomarkerShuo Zeng, Yu-Feng Xiao, Bo Tang, et al.The Oncologist|June 27, 2015
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric CancerKeun-Wook Lee, Kyung Hee Lee, Dae Young Zang, et al.The Oncologist|June 3, 2015
Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in RwandaLydia E Pace, Tharcisse Mpunga, Vedaste Hategekimana, et al.The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.The Oncologist|August 10, 2022
Factors Associated With Physical Activity Levels in Patients With Breast CancerPaulina S Marell, Robert A Vierkant, Janet E Olson, et al.The Oncologist|August 10, 2022
Physician Payments from Pharmaceutical Companies Related to Cancer DrugsAaron P Mitchell, Akriti Mishra Meza, Niti U Trivedi, et al.Pageof 571